BioLytical

The Florida Department of Health (DOH) is seeking to purchase INSTI HIV-1/HIV-2 Antibody Tests from BioLytical Laboratories Inc. The tests are required to detect HIV antibodies up to 9 days earlier than the Western Blot, providing earlier detection and response time. The purchase is intended for a period of one year. The key requirements for the tests include the ability to detect HIV antibodies up to 9 days earlier than the Western Blot and to provide results in 60 seconds. • The purchase is for a single source, with BioLytical Laboratories Inc. being the sole manufacturer and provider of the INSTI HIV-1/HIV-2 Antibody test. • The estimated dollar amount for the purchase is $75,000.00. • The purchase is justified due to the unique nature of the product and the lack of competition. • The DOH is requesting information from prospective vendors regarding their ability to supply the commodities or contractual services described.